What is AngioDynamics's other commercial liabilities?

AngioDynamics (ANGO) reported other commercial liabilities of $32.3M in Q4 2025.

How has AngioDynamics's other commercial liabilities changed year-over-year?

AngioDynamics's other commercial liabilities decreased by 12.6% year-over-year, from $36.95M to $32.3M.

What is the long-term trend for AngioDynamics's other commercial liabilities?

Over 4 years (2021 to 2025), AngioDynamics's other commercial liabilities has grown at a 0.0% compound annual growth rate (CAGR), from $35.46M to $35.52M.

AngioDynamics ANGO Other Commercial Liabilities

Other Commercial Liabilities at other companies

Becton, Dickinson and CompanyBDX

——

TFX

TeleflexTFX

——

Merit Medical SystemsMMSI

——

ICU MedicalICUI

——

Boston ScientificBSX

——

PenumbraPEN

——

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's other commercial liabilities?: AngioDynamics (ANGO) reported other commercial liabilities of $32.3M in Q4 2025.
How has AngioDynamics's other commercial liabilities changed year-over-year?: AngioDynamics's other commercial liabilities decreased by 12.6% year-over-year, from $36.95M to $32.3M.
What is the long-term trend for AngioDynamics's other commercial liabilities?: Over 4 years (2021 to 2025), AngioDynamics's other commercial liabilities has grown at a 0.0% compound annual growth rate (CAGR), from $35.46M to $35.52M.